SRT@ inhibited activation of coagulation , as reflected by lower plasma levels of the prothrombin fragment F@ +@ ( mean peak levels @ % -LSB- p < @ -RSB- and @ % -LSB- p < @ -RSB- after single and repeated SRT@ administration , respectively , relative to those measured after placebo treatment ) .